Naprod Life Sciences, a leading pharmaceutical company, has announced the successful renewal of its European Union Goods Manufacturing Practices (EU-GMP) certification for its manufacturing facility in Palghar.

The certification renewal follows a rigorous audit conducted in December 2023 by The National Institute of Pharmacy and Nutrition, Hungary.

Mohan Jain, Managing Director at Naprod Life Sciences, expressed pride in the achievement, stating, "The EU GMP certification for our facility in Palghar is a testament to our unwavering commitment to upholding the highest quality standards in pharmaceutical manufacturing."

The EU-GMP certification signifies adherence to stringent quality control measures and ensures consistent and controlled production processes in line with the European Union's quality standards. Located in Palghar, the certified facility specializes in producing a diverse range of formulations, including liquid and lyophilized injectable products.

This renewal of EU-GMP certification underscores Naprod Life Sciences' dedication to maintaining excellence in pharmaceutical manufacturing and reaffirms its position as a trusted provider of high-quality pharmaceutical products.